Japan Cell Therapy Market is expected to reach US$ 1,632.99 Million by 2033 | Major Companies - Fujifilm Cellular Dynamics, Inc, Takara Bio Inc, Nipro Corporation, Medinet Ltd.

Market Size and Growth:

The Japan Cell Therapy Market size reached US$ 416.83 Million in 2024 and is expected to reach US$ 1,632.99 Million by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.

The Japan Cell Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/japan-cell-therapy-market?sz

The Japan Cell Therapy Market refers to the development, manufacturing, regulation, and commercialization of cell-based therapies in Japan, including stem cell and immune cell treatments. It is driven by advanced regenerative medicine research, supportive regulatory frameworks, rising chronic diseases, and growing demand for personalized therapies across oncology, orthopedics, and neurological disorders.

Recent Key Developments of Japan:

✅ In November 2025, Novartis expanded access to its CAR-T therapy Kymriah by certifying additional treatment centers under Japan's risk management plan, enhancing availability for relapsed/refractory DLBCL and ALL patients.

✅ In September 2025, Takeda Pharmaceutical discontinued its cell therapy research initiatives, incurring a $395 million impairment loss on its gamma delta T-cell platform and seeking partners for its programs.

✅ In September 2025, Japan launched the JEAP program to accelerate regenerative medicine and cell/gene therapy market entry, providing startups with mentorship, market insights, and connections to local CDMOs, CROs, and pharma partners.

Recent Key Developments of Europe:

✅ In November 2025, the EMA approved the first gene therapy, Waskyra, for Wiskott-Aldrich syndrome, a rare life-threatening immunodeficiency, significantly reducing infections and bleeding episodes.

✅ In October-December 2025 (Q4), clinical trial activity advanced with new programs crossing milestones in precise biology, localized delivery, and early interventions, reflecting a pivot in Europe's cell therapy pipeline.

✅ In Q3 2025 (covering September), ExCellThera's non-genetically modified cell therapy Zemcelpro received EU authorization for treating adults with hematological malignancies.

List of the Key Players in the Japan Cell Therapy Market:

Fujifilm Cellular Dynamics, Inc
Healios K.K.
JCR Pharmaceuticals Co. Ltd.
RIKEN
Takara Bio Inc
Nipro Corporation
Medinet Ltd.
CellSeed Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/japan-cell-therapy-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Japan Cell Therapy Market:

By Therapy Type: Autologous Cell Therapy, Allogeneic Cell Therapy.

By Cell Type: Stem Cells, Non-stem Cells.

By Source: Bone Marrow, Umbilical Cord Blood, Adipose Tissue, Peripheral Blood, Others.

By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Diseases, Wound Healing, Others.

By End User: Hospitals & Clinics​, Academic & Research Institutes, Biopharmaceutical and Biotechnology Companies.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=japan-cell-therapy-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Japan Cell Therapy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Japan Cell Therapy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Japan Cell Therapy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Japan Cell Therapy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Japan Cell Therapy Market in 2025?
◆ What is the projected growth rate of the Japan Cell Therapy Market through 2033?
◆ Who are the key players in the Japan Cell Therapy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.